BCG Vaccination Prevents Insulin-Dependent Diabetes Mellitus (IDDM) in NOD Mice after Disease Acceleration with Cyclophosphamide
- 30 June 1997
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 10 (3) , 271-278
- https://doi.org/10.1006/jaut.1997.0136
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- LONG-TERM SURVIVAL OF SYNGENEIC ISLET GRAFTS IN BCG-TREATED DIABETIC NOD MICE CAN BE REVERSED BY CYCLOPHOSPHAMIDETransplantation, 1995
- Prevention of Diabetes and Insulitis by Neonatal Intrathymic Islet Administration in NOD MiceJournal of Autoimmunity, 1994
- BCG IMMUNOTHERAPY PREVENTS RECURRENCE OF DIABETES IN ISLET GRAFTS TRANSPLANTED INTO SPONTANEOUSLY DIABETIC NOD MICETransplantation, 1994
- Altered Cytokine Activity in Adjuvant Inhibition of Autoimmune DiabetesJournal of Autoimmunity, 1993
- Possible mechanism of the preventive effect of BCG against diabetes mellitus in NOD mouseCellular Immunology, 1991
- Differential expression of the alternatively spliced exons of murine CD45 in Th1 and Th2 cell clonesEuropean Journal of Immunology, 1991
- Anti‐suppressor effect of cyclophosphamide on the development of spontaneous diabetes in nod miceEuropean Journal of Immunology, 1988
- Enhancement of delayed hypersensitivity by depletion of suppressor T cells with cyclophosphamide in miceNature, 1976
- THE MODIFYING EFFECT OF BCG ON THE IMMUNOLOGICAL INDUCTION OF T CELLSThe Journal of Experimental Medicine, 1974
- POTENTIATION OF T-CELL-MEDIATED IMMUNITY BY SELECTIVE SUPPRESSION OF ANTIBODY FORMATION WITH CYCLOPHOSPHAMIDEThe Journal of Experimental Medicine, 1974